Sun Pharmaceutical Industries reports marginal rise in Q3 consolidated net profit

31 Jan 2023 Evaluate

Sun Pharmaceutical Industries has reported results for third quarter ended December 31, 2022.

The company has reported fall of 5.57% in its net profit at Rs 486.73 crore for Q3FY23 as compared to Rs 515.43 crore for the corresponding quarter previous year. However, total income of the company increased by 15.65% to Rs 4,713.78 crore for the quarter under review as compared to Rs 4,075.89 crore for the same quarter in the previous year.

On the consolidated basis, the company has reported rise of 2.69% in its net profit at Rs 2,188.04 crore for Q3FY23 as compared to Rs 2,130.80 crore for the same quarter in the previous year. However, total income of the company increased by 10.87% to Rs 11,414.85 crore for the quarter under review as compared to Rs 10,295.57 crore for the same quarter in the previous year.

Sun Pharma Inds. Share Price

1507.85 -9.30 (-0.61%)
19-Apr-2024 10:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1507.85
Dr. Reddys Lab 5917.15
Cipla 1339.85
Zydus Lifesciences 930.75
Lupin 1570.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.